[go: up one dir, main page]

WO2008107502A8 - Composicion para el tratamiento de enfermedades infecciosas - Google Patents

Composicion para el tratamiento de enfermedades infecciosas Download PDF

Info

Publication number
WO2008107502A8
WO2008107502A8 PCT/ES2008/000098 ES2008000098W WO2008107502A8 WO 2008107502 A8 WO2008107502 A8 WO 2008107502A8 ES 2008000098 W ES2008000098 W ES 2008000098W WO 2008107502 A8 WO2008107502 A8 WO 2008107502A8
Authority
WO
WIPO (PCT)
Prior art keywords
infectious diseases
group
teating
composition
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES2008/000098
Other languages
English (en)
French (fr)
Other versions
WO2008107502A1 (es
Inventor
Sanz Javier Sancho
Campoy Andrian Velazquez
Casasin Nunilo Cremades
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Zaragoza
Original Assignee
Universidad de Zaragoza
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Zaragoza filed Critical Universidad de Zaragoza
Priority to JP2009551231A priority Critical patent/JP5523841B2/ja
Priority to US12/529,626 priority patent/US8461202B2/en
Priority to EP08750368A priority patent/EP2135858A4/en
Publication of WO2008107502A1 publication Critical patent/WO2008107502A1/es
Publication of WO2008107502A8 publication Critical patent/WO2008107502A8/es
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/01—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms
    • C07C205/03—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C205/04—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/08—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to acyclic carbon atoms
    • C07C205/09—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/16—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being unsaturated and containing rings
    • C07C305/18—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being unsaturated and containing rings containing six-membered aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Compuesto de formula general (I)1 o cualquiera de sus sales, para su uso como composición farmacéutica para el tratamiento de enfermedades infecciosas, mas particularmente para el tratamiento de enfermedades causadas por Helicobacter. R1 es un átomo de H, X o un radical CXmH3-m; X representa un halógeno seleccionado de entre F, Cl, Br o I, y pueden ser igual o diferente, m toma valores de entre 1 a 3; R2 es un grupo NO2, COOR' o SO3R'; R' representa un átomo de hidrógeno (H) o un grupo C1- C6 alquilo; y n de entre 1 a 5.
PCT/ES2008/000098 2007-03-02 2008-02-22 Composicion para el tratamiento de enfermedades infecciosas Ceased WO2008107502A1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2009551231A JP5523841B2 (ja) 2007-03-02 2008-02-22 感染症の治療のための組成物
US12/529,626 US8461202B2 (en) 2007-03-02 2008-02-22 Composition for treating infectious diseases
EP08750368A EP2135858A4 (en) 2007-03-02 2008-02-22 COMPOSITION FOR TREATING INFECTIOUS DISEASES

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP200700645 2007-03-02
ES200700645A ES2304220B1 (es) 2007-03-02 2007-03-02 Composicion para el tratamiento de enfermedades infecciosas.

Publications (2)

Publication Number Publication Date
WO2008107502A1 WO2008107502A1 (es) 2008-09-12
WO2008107502A8 true WO2008107502A8 (es) 2009-07-23

Family

ID=39731846

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2008/000098 Ceased WO2008107502A1 (es) 2007-03-02 2008-02-22 Composicion para el tratamiento de enfermedades infecciosas

Country Status (5)

Country Link
US (1) US8461202B2 (es)
EP (1) EP2135858A4 (es)
JP (1) JP5523841B2 (es)
ES (1) ES2304220B1 (es)
WO (1) WO2008107502A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2786927T3 (es) 2013-12-03 2020-10-14 Fmc Corp Pirrolidinonas como herbicidas
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
KR102479858B1 (ko) 2014-07-02 2022-12-21 에프엠씨 코포레이션 피페리디논계 제초제
US10227286B2 (en) 2014-12-08 2019-03-12 Fmc Corporation 3-oxo-3-(arylamino)propanoates, a process for their preparation, and their use in preparing pyrrolidinones
US10405547B2 (en) 2015-04-10 2019-09-10 Fmc Corporation Substituted cyclic amides as herbicides
RU2734932C2 (ru) 2015-04-27 2020-10-26 ЭфЭмСи Корпорейшн Бутиролактоны в качестве гербицидов
CN107592862B (zh) 2015-05-12 2021-06-15 Fmc公司 作为除草剂的芳基取代的双环化合物
EP3303287B1 (en) 2015-05-29 2020-12-16 FMC Corporation Substituted cyclic amides as herbicides
AU2016271374B2 (en) 2015-06-02 2020-11-26 Fmc Corporation Substituted cyclic amides and their use as herbicides
RU2720994C2 (ru) 2015-07-31 2020-05-15 Е.И.Дюпон Де Немур Энд Компани Новые соединения циклического n-карбоксамида, применяемые в качестве гербицидов
JP7325328B2 (ja) 2016-12-21 2023-08-14 エフ エム シー コーポレーション ニトロン除草剤
CN110691516B (zh) 2017-03-21 2022-10-28 Fmc公司 吡咯烷酮及其制备方法
UA126576C2 (uk) 2017-03-21 2022-11-02 ЕфЕмСі КОРПОРЕЙШН Гербіцидна суміш, композиція та спосіб
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3394191A (en) 1966-02-09 1968-07-23 Monsanto Co Phenyl beta-nitrostyryl sulfides
US3629465A (en) 1966-08-22 1971-12-21 Givaudan Corp Preservatives for aqueous systems
US3985761A (en) 1974-10-24 1976-10-12 Sarabhai Research Centre Nitrothiazolyl derivatives of nitrostyrene
AU8276187A (en) * 1986-10-31 1988-05-25 Warner-Lambert Company Selected n6-substituted adenosines having selective a2 binding activity
US5180733A (en) * 1990-03-30 1993-01-19 Abbott Laboratories Biogenic amine uptake inhibitors
JPH04193850A (ja) * 1990-11-27 1992-07-13 Yoshitomi Pharmaceut Ind Ltd β―ニトロスチレン化合物の製造法
JP3547783B2 (ja) * 1993-12-28 2004-07-28 ロート製薬株式会社 胃炎、胃・十二指腸潰瘍の予防及び治療剤
US5763470A (en) 1995-06-07 1998-06-09 Sugen Inc. Benzopyran compounds and methods for their use
GB9526407D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Substances and their uses
JPH11106335A (ja) * 1997-09-30 1999-04-20 Hayashibara Biochem Lab Inc 抗ヘリコバクター・ピロリ剤
TR200101749T2 (tr) * 1998-12-17 2001-10-22 F.Hoffmann-La Roche Ag Apoptosis'i teşvikleyici bileşikler olarak 7-aril-6(Z)heptatrienoik asit retinamidler.
DE10045599B4 (de) 2000-09-15 2004-06-03 Wella Ag Haarfärbemittel auf der Basis von 4-Nitro-2,1,3-benzoxadiazol-Derivaten und dessen Verwendung als Farbstoff zum Färben von Haaren
US20040167189A1 (en) 2002-03-22 2004-08-26 The Government Of The U.S.A., As Represented By The Secretary, Dept. Of Health And Human Services Materials and methods for inhibiting Wip1
KR100614422B1 (ko) * 2002-11-15 2006-08-21 주식회사디엔에이링크 베타-니트로스티렌계 화합물 및 이를 함유하는 항암 조성물
ITRM20030194A1 (it) 2003-04-24 2004-10-25 Univ Roma Uso di derivati del 7-nitro-2, 1, 3-benzossadiazolo per
WO2005019177A1 (en) * 2003-08-14 2005-03-03 Icos Corporation Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof
JP3991026B2 (ja) * 2003-12-01 2007-10-17 ロート製薬株式会社 胃炎、胃・十二指腸潰瘍の予防及び治療剤
WO2005082341A2 (en) 2004-02-23 2005-09-09 Prolexys Pharmaceuticals Inc. NON-PEPTIDYL AGENTS WITH pHSP20-LIKE ACTIVITY, AND USES THEREOF
JP2008503591A (ja) 2004-06-22 2008-02-07 ライジェル ファーマシューティカルズ， インコーポレイテッド ユビキチンリガーゼ阻害剤

Also Published As

Publication number Publication date
US8461202B2 (en) 2013-06-11
ES2304220A1 (es) 2008-09-16
ES2304220B1 (es) 2009-09-11
JP2010521424A (ja) 2010-06-24
JP5523841B2 (ja) 2014-06-18
US20100087690A1 (en) 2010-04-08
EP2135858A1 (en) 2009-12-23
EP2135858A4 (en) 2012-02-08
WO2008107502A1 (es) 2008-09-12

Similar Documents

Publication Publication Date Title
WO2008107502A8 (es) Composicion para el tratamiento de enfermedades infecciosas
NO20084005L (no) Aminderivater
PT2192109E (pt) Derivado de -aminoácido bicíclico
MY153045A (en) Oxopyrazine derivative and herbicide
TW200833675A (en) Nicotinamide derivatives
WO2008030744A3 (en) Inhibitors of c-met and uses thereof
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
NO20091704L (no) Inhibitorer av hepatitt C virus
NO20091707L (no) Inhibitorer av hepatitt C virus
NO20091706L (no) Inhibitorer av hepatitt C virus
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
WO2008051873A3 (en) Phenylurea compounds as soluble epoxide hydrolase inhibitors
MD4302B1 (ro) Compoziţii erbicide ce conţin un derivat al benzoilpirazolului
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
UA99447C2 (ru) Способ получения силденафила
WO2008014955A3 (en) Fungicidal compounds and compositions
GEP20115166B (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
WO2009118473A3 (fr) Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
WO2008052379A3 (en) Organic compounds
UA105022C2 (uk) Композиція для боротьби з хворобами рослин та спосіб боротьби з хворобами рослин
ATE503746T1 (de) Neue imidazolidinderivate
DK2000473T3 (da) Trehalose-forbindelse og lægemiddel omfattende forbindelsen
MX2009008324A (es) Compuestos 6´-sustituidos que tienen afinidad con el receptor de 5-hidroxitriptamina-6.
MX2011009806A (es) Nuevos derivados de indazol inhibidores de hsp90, composiciones que los contienen y su uso.
MX2010006446A (es) Nuevos derivados de diazeniodiolato, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08750368

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2008750368

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2009551231

Country of ref document: JP

Ref document number: 2008750368

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 12529626

Country of ref document: US